R. Andrew Eckert

Strategic Advisor at Sumeru Equity Partners LP

R. Andrew Eckert

R. Andrew Eckert

Strategic Advisor at Sumeru Equity Partners LP

Overview
Career Highlights

Acelity LP, Inc.
Acelity Holdings, Inc.
Valence Health, Inc.

RelSci Relationships

1236

Number of Boards

14

Birthday

1961

Age

57

Relationships
RelSci Relationships are individuals R. Andrew Eckert likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Avanos Medical, Inc.

Relationship likelihood: Strong

Senior Principal at Canada Pension Plan Investment Board Private Investments

Relationship likelihood: Strong

Partner, Healthcare at APAX PARTNERS LLP

Relationship likelihood: Strong

Co-Founder, Chairman & Chief Executive Officer at CRC Health Group

Relationship likelihood: Strong

Chairman, Therapy Systems Division at National Electrical Manufacturers Association

Relationship likelihood: Strong

Executive Vice President, General Counsel & Secretary at Acelity LP, Inc.

Relationship likelihood: Strong

Partner & Chairman US, Consumer at APAX PARTNERS LLP

Relationship likelihood: Strong

Founder at HealthSpring, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Alcon Laboratories, Inc. Veba Trust I

Relationship likelihood: Strong

President & Chief Executive Officer at Varian Medical Systems, Inc.

Relationship likelihood: Strong

Paths to R. Andrew Eckert
Potential Connections via
Relationship Science
You
R. Andrew Eckert
Strategic Advisor at Sumeru Equity Partners LP
Education
MBA
Class of 1988

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Bachelor's of Science in Industrial Engineering
Class of 1983

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
President, Chief Executive Officer & Director
2017 - Current

Acelity LP, Inc. operates as a holding company with interest in the research and development, manufacture, and marketing of regenerative medicines. It operates through Advanced Wound Therapeutics and Regenerative Medicine segments. The Advanced Wound Therapeutics segment focuses on the development and commercialization of healing solutions such as negative pressure wound therapy, advanced dressings, negative pressure surgical management and epidermal harvesting. The Regenerative Medicine segment offers regenerative and reconstructive solutions to repair soft tissue defects and autologous fat grafting solutions. The company was founded in 2014 is headquartered in San Antonio, TX.

President, Chief Executive Officer & Director
Current

Acelity Holdings, Inc. is a wound care and regenerative medicine company. It operates its business through two segments: Wound Therapeutics and Regenerative Medicine. The Wound Therapeutics segment focuses on the development and commercialization of advanced devices and advanced wound dressings. The Regenerative Medicine segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to reinforce soft tissue defects. The company was founded on August 13, 2015 and is headquartered in San Antonio, TX.

Executive Advisor
Current

Long River invests in early-stage information technology, health care, communications, and other technology-driven product, manufacturing and service businesses.

Boards & Committees
President, Chief Executive Officer & Director
2017 - Current

Acelity LP, Inc. operates as a holding company with interest in the research and development, manufacture, and marketing of regenerative medicines. It operates through Advanced Wound Therapeutics and Regenerative Medicine segments. The Advanced Wound Therapeutics segment focuses on the development and commercialization of healing solutions such as negative pressure wound therapy, advanced dressings, negative pressure surgical management and epidermal harvesting. The Regenerative Medicine segment offers regenerative and reconstructive solutions to repair soft tissue defects and autologous fat grafting solutions. The company was founded in 2014 is headquartered in San Antonio, TX.

Independent Director
2016 - Current

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Chairman, Board of Directors
2004 - Current

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Varian Particle Therapy segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Varian Particle Therapy segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

Board Member
Current

California Trout was established in 1971 for the purpose of undertaking programs and activities To protect and restore wild trout, steelhead, salmon and their waters throughout California.

Public Holdings
Restricted data only for RelSci Professional users.